Lena Kanter-Lewensohn
Overview
Explore the profile of Lena Kanter-Lewensohn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zebary A, Omholt K, Vassilaki I, Hoiom V, Linden D, Viberg L, et al.
J Dermatol Sci
. 2013 Sep;
72(3):284-9.
PMID: 23993026
Background: Acral lentiginous melanoma (ALM) accounts for <10% of all melanomas in Caucasians. Although the involvement of KIT, NRAS and BRAF mutations is well known in ALM, the impact of...
2.
Zebary A, Omholt K, van Doorn R, Ghiorzo P, Harbst K, Hertzman Johansson C, et al.
J Invest Dermatol
. 2013 Jun;
134(1):287-290.
PMID: 23771122
No abstract available.
3.
Eriksson H, Frohm-Nilsson M, Hedblad M, Hellborg H, Kanter-Lewensohn L, Krawiec K, et al.
Acta Derm Venereol
. 2013 Jan;
93(4):411-6.
PMID: 23306667
Clinical management of primary cutaneous melanomas is based on histopathological staging of the tumour. The aim of this study was to investigate, in a non-selected population in clinical practice, the...
4.
Omholt K, Grafstrom E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding B
Clin Cancer Res
. 2011 Jun;
17(12):3933-42.
PMID: 21680547
Purpose: A significant proportion of mucosal melanomas contain alterations in KIT. The aim of this study was to characterize the pattern of KIT, NRAS, and BRAF mutations in mucosal melanomas...
5.
Lundberg R, Brytting M, Dahlgren L, Kanter-Lewensohn L, Schloss L, Dalianis T, et al.
Anticancer Res
. 2006 Nov;
26(5B):3627-31.
PMID: 17094377
Background: UV-radiation is the most important causative factor for malignant melanomas of the skin. However, this is not the case for melanomas on sun-sheltered body surfaces. The aim of this...
6.
Dahlgren L, Schedvins K, Kanter-Lewensohn L, Dalianis T, Ragnarsson-Olding B
Acta Oncol
. 2005 Oct;
44(7):694-9.
PMID: 16227159
Human papillomavirus (HPV) has been associated with some types of human cancer. The aim of this study was to investigate if HPV could be associated with human primary malignant melanoma...
7.
Lundberg L, Hellstrom-Lindberg E, Kanter-Lewensohn L, Lerner R, Palmblad J
Leuk Res
. 2005 Aug;
30(3):247-53.
PMID: 16099505
The International Prognostic Scoring System (IPSS), based on the number of cytopenias, percentage of bone marrow blasts and cytogenetics, is an important prognostic tool for patients with myelodysplastic syndrome (MDS)....
8.
Friesland S, Kanter-Lewensohn L, Tell R, Munck-Wikland E, Lewensohn R, Nilsson A
Head Neck
. 2003 Mar;
25(4):313-21.
PMID: 12658736
Background: To determine possible molecular markers for predicting radiosensitivity in squamous cell carcinoma, we have examined the relationship between pretreatment expression of the DNA damage recognition complex DNA-PK, its in...
9.
Hellstrom-Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl I, Dybedal I, et al.
Br J Haematol
. 2003 Mar;
120(6):1037-46.
PMID: 12648074
We have published previously a prototype of a decision model for anaemic patients with myelodysplastic syndromes (MDS), in which transfusion need and serum erythropoietin (S-Epo) were used to define three...